Try our mobile app

Published: 2023-06-06 06:03:38 ET
<<<  go to CLVT company page
clvt-20230606
Jersey0001764046false00-000000000017640462023-06-062023-06-060001764046us-gaap:CommonStockMember2023-06-062023-06-060001764046us-gaap:SeriesAPreferredStockMember2023-06-062023-06-060001764046clvt:PreferredStockPurchaseRightsMember2023-06-062023-06-06

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

June 6, 2023
Date of Report (date of earliest event reported)

CLARIVATE PLC
(Exact name of registrant as specified in its charter)
Jersey, Channel Islands
(State or other jurisdiction of incorporation or organization)
001-38911
(Commission File Number)
N/A
(I.R.S. Employer Identification No.)
70 St. Mary Axe
London
EC3A 8BE
United Kingdom
(Address of Principal Executive Offices)
(44) 207-433-4000
Registrant's telephone number, including area code

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Ordinary Shares, no par valueCLVTNew York Stock Exchange
5.25% Series A Mandatory Convertible Preferred Shares, no par valueCLVT PR ANew York Stock Exchange
Series B Preferred Stock Purchase Rights-New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.



Item 7.01. Regulation FD Disclosure.

Clarivate Plc (the “Company” or “Clarivate”) will present at the William Blair Growth Stock Conference on Tuesday, June 6, 2023 at 3:20 pm Central Time (4:20 pm Eastern Time). The live webcast can be accessed at https://wsw.com/webcast/blair79/clvt/1954890 and will be available for replay.

The Company will also present at the Stifel 2023 Cross Sector Insight Conference on Wednesday, June 7, 2023 at 8:00 am Eastern Time. The live webcast can be accessed at https://wsw.com/webcast/stifel80/clvt/2107575 and will be available for replay.

See Exhibit 99.1 for certain presentations that Company management is delivering at the William Blair and Stifel conferences, including an overview of the Company’s business and financial performance. From time to time, the Company may also use these presentations in conversations with investors and analysts.

The information in this Item 7.01, including Exhibit 99.1 furnished herewith, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section and shall not be incorporated by reference into any registration statement or other filing pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly stated in such filing.


Item 9.01.    Financial Statements and Exhibits
(d) Exhibits.
No.Description
99.1
104Cover page of this Current Report on Form 8-K formatted in Inline XBRL



SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 CLARIVATE PLC
 
Date: June 6, 2023By: /s/ Jonathan Collins
 Name: Jonathan Collins
 
Executive Vice President & Chief Financial Officer